Assertio Holdings | DEPO - Cash And Equivalent

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $38.5M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
ANI Pharmaceuticals USD 285.58M 22.98M Dec/2025
Assertio Holdings USD 38.5M 8.59M Sep/2025
Aurora Cannabis CAD 56.36M 39.33M Dec/2025
Cara Therapeutics USD 21.42M 770K Sep/2025
Daiichi Sankyo JPY 542.16B 97.68B Sep/2025
Ironwood Pharmaceuticals USD 140.41M 47.56M Sep/2025
J&J USD 19.71B 1.48B Dec/2025
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Merck USD 18.17B 10.16B Sep/2025
Nektar Therapeutics USD 15.12M 25.92M Dec/2025
Omeros USD 1.9M 2.36M Jun/2025
Pfizer USD 1.34B 295M Sep/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025